Shopping Cart
- Remove All
Your shopping cart is currently empty
FGFR4-IN-20 (comp 11) is an orally active and selective FGFR4 inhibitor, demonstrating IC50 values of 19 nM against Huh7 cells and 36 nM for FGFR4 kinase. It is utilized in hepatocellular carcinoma research.

| Description | FGFR4-IN-20 (comp 11) is an orally active and selective FGFR4 inhibitor, demonstrating IC50 values of 19 nM against Huh7 cells and 36 nM for FGFR4 kinase. It is utilized in hepatocellular carcinoma research. |
| In vitro | FGFR4-IN-20 exhibits IC50 values of 19 nM, 16 nM, and 33 nM against Huh7 (FGFR overexpression), Hep3B (FGF19 treatment), and JHH-7 (FGF19 treatment) cell lines, respectively, in the concentration range of 0.01-1000 nM. |
| In vivo | FGFR4-IN-20, administered orally at a dose of 100 mg/kg once daily for 15 days, significantly reduces tumor volume in ICR mice without causing weight loss or other clinical signs. |
| Formula | C26H22Cl2N4O3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.